Thought Leadership
The Center for Biosimilars Interview: Axinn IP Chair Provides Analysis of Biden Biosimilars Initiative
July 14, 2021
The Center for Biosimilars

Axinn partner Chad Landmon participated in a video interview with The Center for Biosimilars, where he discussed the Biden Biosimilars initiative. During the interview, he put these initiatives into context with background information and insight into the likely pharmaceutical industry impact and response.

Click here to access the interview.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.